Baxter International logged a 0.4% change during today's morning session, and is now trading at a price of $35.94 per share. The S&P 500 index moved 0.0%. BAX's trading volume is 782,064 compared to the stock's average volume of 5,083,563.
Baxter International trades -15.97% away from its average analyst target price of $42.77 per share. The 13 analysts following the stock have set target prices ranging from $35.0 to $53.0, and on average have given Baxter International a rating of hold.
If you are considering an investment in BAX, you'll want to know the following:
-
Baxter International's current price is -16.4% below its Graham number of $42.99, which implies the stock has a margin of safety
-
Baxter International has moved -31.0% over the last year, and the S&P 500 logged a change of 17.0%
-
Based on its trailing earnings per share of 0.46, Baxter International has a trailing 12 month Price to Earnings (P/E) ratio of 78.1 while the S&P 500 average is 15.97
-
BAX has a forward P/E ratio of 11.9 based on its forward 12 month price to earnings (EPS) of $3.02 per share
-
The company has a price to earnings growth (PEG) ratio of 2.92 — a number near or below 1 signifying that Baxter International is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 2.25 compared to its sector average of 4.08
-
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
-
Based in Deerfield, the company has 60,000 full time employees and a market cap of $18.23 Billion. Baxter International currently returns an annual dividend yield of 3.2%.